4 Reasons to Choose Israel for B-cell Non-Hodgkin’s Lymphoma Treatment

Israel, and Sheba Medical center in particular, are world leaders in the implementation of CAR T-cell therapy for lymphoma patients. CAR T-cell therapy is an innovative procedure that makes use of your own immune system to seek and destroy cancerous cells. After some blood is taken from the patient, the T-cells, a type of immune cell, are separated from the rest of the blood in a special laboratory. The T-cells are then genetically engineered to produce chimeric antigen receptors (CARs). The engineered T-cells are then given some time to multiply in the laboratory and are later injected back into the patient. The CARs allow the T-cells to recognize, target, and destroy cancer cells.
Unfortunately, as a novel advanced treatment, CAR T-cell therapy is only available in a handful of medical institutions worldwide and tends to be very expensive. At Sheba Medical Center, CAR T-cells are engineered in-house in a specialized laboratory, and as a result, the entire process, from lymphocyte collection to patient delivery, only takes about 10 days. In contrast, many other hospitals use commercial CARs, which must be engineered abroad and shipped back, taking months to become available. This delay allows the patient’s disease to progress further, which can also reduce the effectiveness of the body’s response to the CARs. Furthermore, the shipping process compromises cell quality, as some cells die during the necessary freezing and thawing.

Having discovered a few of the many advantages of getting B-cell non-Hodgkin’s lymphoma treatment in Israel, where exactly should you pursue it? Sheba Medical Center is an exceptional choice. The largest hospital in Israel, and one of the 10 best hospitals in the world according to Newsweek magazine, Sheba is dedicated to providing patients with world-class medical care.

The advantages of receiving treatment at Sheba Medical Center include:

• Sheba’s 360-degree care approach to every patient, which means that Sheba’s professionals will assist you with arranging medical record reviews, travel, visas, accommodations, and language interpretation as needed.
• As a government institution, we have no hidden costs, and our fees are transparent. Although we offer advanced treatments that are available only in select medical institutions around the world, our prices are affordable.
• Sheba’s extensive experience with CAR T-cell therapy speaks louder than words. Under the expertise of Prof. Arnon Nagler, Director of the Hemato-Oncology Division, and a world-renowned specialist in the field, we have provided over 220 patients with CAR T-cell therapy, including 60 children.
• Sheba has full accreditation from the Joint Commission International (JCI), the premier international healthcare accrediting group.
• Sheba has both advanced treatment and laboratory facilities. At Sheba, patients receive every aspect of their treatment in a single facility.